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Wheat amylase/trypsin bi-functional inhibitors (ATIs) are protein stimulators of innate immune 
response, with a recently established role in promoting both gastrointestinal and extra-gastrointestinal 
inflammatory syndromes. These proteins have been reported to trigger downstream intestinal 
inflammation upon activation of TLR4, a member of the Toll-like family of proteins that activates 
signalling pathways and induces the expression of immune and pro-inflammatory genes. In this study, 
we demonstrated the ability of ATI to directly interact with TLR4 with nanomolar affinity, and we 
kinetically and structurally characterized the interaction between these macromolecules by means of a 
concerted approach based on surface plasmon resonance binding analyses and computational studies. 
On the strength of these results, we designed an oligopeptide capable of preventing the formation of 
the complex between ATI and the receptor.
In the last decades, the implementation of novel agricultural practices contributed positively to the decrease 
of costs associated with large-scale production of wheat-based food. Consequently, the higher consumption of 
breads and pastas caused a predictable increase in hypersensitization to wheat. The most common of these disor-
ders include baker’s asthma1, and immune reactions to wheat ingestion, such as celiac disease (CD), wheat allergy 
(WA), and non-celiac gluten/wheat sensitivity (NCGS or NCWS)2–5.
CD is triggered by gluten peptides that induce the adaptive immune response in predisposed individuals, 
resulting in the activation of T-cells6,7, whereas IgE antibodies are induced by wheat proteins in WA, eventually 
stimulating the release of immune mediators8.
On the other hand, NCGS is associated with innate immune activation, which is likely stimulated by wheat 
proteins9,10. NCGS presents also extra-intestinal symptoms11, such as confusion and headache, chronic fatigue, 
joint/muscle pain, and the exacerbation of pre-existing neurological, psychiatric, or (auto-)immune diseases4,12,13.
Based on their structural, chemical and physical properties10, wheat proteins are generally categorized as albu-
mins and globulins (15% of total protein content), and gluten (85% of total protein content). Specifically, gluten 
consists of a complex mixture of monomeric gliadins and polymeric glutenins, whereas albumins and globulins 
comprise several families of proteins, such as the α-amylase/trypsin inhibitors (ATIs), β-amylases, peroxidases, 
lipid transfer proteins, and serine proteases inhibitors10. In the quest to identify wheat components effectively 
responsible for the initiation of innate immune response, ATIs were demonstrated as potent activators of myeloid 
cells. Specifically, ATIs directly engage TLR4–MD2–CD14 complex and activate both nuclear factor kappa B and 
interferon responsive factor 3 pathways, resulting in the up-regulation of maturation markers and the release of 
proinflammatory innate cytokines14. The centrality of TLR4 system was further confirmed, as animal models 
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deficient in TLR4 were protected from the intestinal and systemic immune responses upon oral challenge with 
ATIs15.
Compared to other protein constituents, ATIs represent a minor, but still significant part of total wheat pro-
teins (2–4%)16, on average, an adult person being exposed up to 1 g of ATIs per day: in fact, ATIs are present and 
even enriched in commercial wheat-based food17, and can escape proteolytic digestion by pepsin and trypsin, 
preserving the TLR4-activating ability after intestinal transit upon oral ingestion18.
Structurally, wheat ATIs belong to a group of hydrolase-resistant proteins stabilized by inter-molecular 
disulfide bonds19, and with high secondary structural homology15. They can be further divided into three 
sub-groups constituted by monomeric and (non-covalently linked) dimeric and tetrameric forms20. ATIs are 
found in the endosperm of plant seeds, where they represent part of the natural defence against parasites and 
insects, as well as regulatory molecules of starch metabolism during seed development and germination21,22. 
Plants other than wheat, such as rye and barley also contain similar bi-functional inhibitors, but show only min-
imal or absent TLR4-activating activity15.
Due to the in vivo TLR4 stimulatory activity and resistance to gastrointestinal proteolysis15, this latter being 
attributable to the potent inhibitory activity toward diverse hydrolases23, ATIs may exert a pathogenic role in 
inflammatory, metabolic and autoimmune diseases and in NCGS11,24,25.
On the strength of the interplay between ATIs and TLR4, in this study we used the IAsys plus system to explore 
the kinetics of the interaction between a representative member of wheat ATI family, namely CM3, and human 
TLR4. In addition, we performed molecular docking studies to predict the structural basis of ATI-TLR4 complex, 
evaluating the most probable binding sites and interaction forces, and identifying the residues at the binding 
interface. Interestingly, besides revealing univocally a high-affinity interaction between the two macromolecules, 
the results of the concerted computational and binding studies led to design an oligopeptide constituting part of 
the discontinuous ATI binding interface with TLR4, which was able to prevent the interaction between the two 
macromolecules.
Results
Biosensor binding studies. Carboxylate cuvettes were selected to covalently immobilize TLR4 via primary 
amines. The very high stability of the resulting biosensing layer combined with the low instrumental short-term 
noise (less than 1 arcsec) granted an accurate determination of both kinetic and equilibrium parameters of the 
interaction between human TLR4 and wheat ATI CM3 under different pH and ionic strength conditions. The 
superimposition of representative association kinetics obtained upon binding of different concentrations of ATI 
to TLR4 (PBS pH 7.4, supplemented with 140 mM NaCl) is reported in Fig. 1, Panel A. Raw data were routinely 
accumulated over a 6-min interval. Association and dissociation curves were fitted to both mono- and bi-expo-
nential models: since bi-exponential models did not significantly improve the quality of fits, as judged by standard 
F-test, 95% confidence, the mono-exponential models (Eqq. 3 and 5, see Method section) were used throughout 
to analyse the data.
This experimental approach evidenced the high-affinity interaction between soluble ATI and surface-blocked 
receptor (KD, kin = (6.1 ± 1.7) × 10−8 M, as calculated from the ratio of kinetic parameters derived from Eq. 2). 
Both fast association (kass = (4.1 ± 0.6) × 104 M−1 s−1) and slow dissociation (kdiss = (2.5 ± 0.6) × 10−3 s−1) phases 
significantly contributed to the stabilization of the complex.
The binding response at equilibrium (extent of binding) was calculated for each time course, with fully com-
parable equilibrium dissociation constant value (KD, ext = (3.6 ± 1.5) × 10−8 M, as directly calculated from Eq. 4) 
with respect to values derived from kinetic analyses (Fig. 1, Panel B).
Figure 1. Binding of ATI to surface-blocked TLR4. Superimposition of sensorgrams obtained at increasing 
concentrations of the bi-functional inhibitor (Panel A). Extent of binding vs concentration plot (Panel B).
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Binding stoichiometry was determined to be 1:1, as calculated from the molar ratio between surface-blocked 
TLR4 (59 μM, directly estimated from the biosensor response upon immobilization) and soluble ATI (60 μM, 
derived from the extent of binding at saturating concentration of the bi-functional inhibitor).
Effect of pH and ionic strength. We investigated the influence of pH and ionic strength on the kinetic 
and equilibrium parameters of the binding between ATI and TLR4 (all parameters are summarized in Table 1). 
At lower salt concentrations, negatively-charged TLR4 bound with higher affinity to ATI, exclusively due to the 
higher kinetic stability of the ATI-TLR4 complex (lower value of kinetic dissociation constant). Both complex 
affinity and kinetic stability progressively decreased with increasing ionic strength, with a final 25-fold loss in 
complex stability (as also evident from the progressive increase in the slope of the dissociation phases with NaCl 
concentration, Fig. 2). For this reason, we used PBS supplemented with 200 mM NaCl instead of using HCl 
10 mM for the regeneration step (this procedure being likely to cause denaturation of the macromolecule blocked 
on the cuvette surface). Conversely, kinetics of association were not affected by salt concentration, the changes in 
kass values being negligible within experimental errors.
Neither kinetic nor equilibrium parameters showed significant dependence from pH in the range 6–8 (data 
not shown).
Electrostatic potential maps. ATI-TLR4 complex was mainly stabilized by electrostatic interactions. 
In fact, TLR4 revealed a large, global negative charge (for pH values higher than 5), whereas ATI, presenting 
both positively and negatively charged surfaces, was supposed to act as a protein dipole (See Supplementary 
Information). These results were in good agreement with the effects induced by changes in the dielectric con-
stant of the buffer solution on complex stability (high ionic strength conditions strongly destabilized ATI-TLR4 
complex).
Docking analysis of ATI to TLR4. Docking studies between the fold-recognition model of wheat ATI CM3 
(see Experimental Section for details) and the X-ray crystal structure of the human TLR4-MD2 complex dis-
closed new insights regarding both the nature of the interaction and the binding geometry of the complex. The 
inner β-strand rich region of human TLR4 was calculated to be the most likely to accommodate the ATI molecule 
(Fig. 3, Panel A), with a predicted equilibrium dissociation constant of 9 × 10−8 M, in excellent agreement with 
the experimental results. Predictive ATI-TLR4 binding interface regions are shown in Fig. 3, Panel A, and amino 
acid sequences are presented in Fig. 3, Panel B.
Binding of ATI upon enzymatic digestion. Based on the results of docking and predictive protease cleav-
age sites studies, a minor portion of the discontinuous ATI binding interface was unaffected by pepsin treatment. 
The binding to TLR4 was tested also upon digestion of ATI with pepsin under both reducing and non-reducing 
conditions (Fig. 4), since native wheat ATIs are strongly stabilized by four intramolecular disulfide bonds, which 
confer resistance to enzymatic hydrolysis. As evident from the comparison of equilibrium dissociation constants, 
ATI largely preserved its binding ability upon digestion under non-reducing conditions (native ATI is strongly 
stabilized by four intramolecular disulfide bonds, which confer resistance to enzymatic hydrolysis), with a nearly 
8-fold decrease in KD, exclusively attributable to the less favourable recognition phase (Table 2). Conversely, the 
digestion of ATI under reducing and acetylating conditions with 2-mercaptoethanol and iodoacetamide yielded 
a product still capable of binding to TLR4. This product displayed further lower affinity for TLR4 (nearly 43-fold 
lower than undigested ATI), both association and dissociation rates being significantly affected by the treatment.
Competitive binding of a short ATI-derived peptide to TLR4. The results of computational analyses 
led to the identification of an oligopeptide (amino acid sequence: RSGNVGESGLI) constituting a significant por-
tion of the discontinuous ATI binding interface to TLR4. This oligopeptide can largely escape pepsin digestion 
(the analysis of predictive protease cleavage sites with PeptideCutter26 evidenced the hydrolysis of only the last 
residue of the motif bearing the sequence of interest, as shown in Fig. 4), and (most importantly) is likely to antag-
onize ATI action by interfering with the formation of the ATI-TLR4 complex. In fact, according to molecular 
docking analysis with Autodock Vina, the peptide accommodated in a region of TLR4 constituting part of ATI 
binding interface: more specifically, Arg115 residue at the amino-terminal end of the RSGNVGESGLI peptide was 
predicted to interact with Asp379 present in TLR4, while Val119 of the oligopeptide is in contact with Tyr403 and 
Tyr451 residues of TLR4 (see Supplemental Material).
According to this premise, first we tested the ability of the oligopeptide to effectively bind to TLR4 using 
the same biosensor-based assay described above. The oligopeptide exhibited specific binding to the extracel-
lular domain of TLR4 (Fig. 5, Panel A) with a 1:1 binding stoichiometry, (calculated as described above for the 
Ionic strength conditions kass (M−1s−1) kdiss (s−1) KD (M)
20 mM PBS (no NaCl) 43000 ± 2000 0.0001 ± 0.00005 (2.3 ± 1.2) × 10−9
20 mM PBS (25 mM NaCl) 39000 ± 4000 0.0004 ± 0.0002 (1.0 ± 0.5) × 10−8
20 mM PBS (50 mM NaCl) 40000 ± 2500 0.0007 ± 0.0001 (1.8 ± 0.3) × 10−8
20 mM PBS (140 mM NaCl) 41000 ± 6000 0.0025 ± 0.0006 (6.1 ± 1.7) × 10−8
Table 1. Effect of ionic strength on kinetic and equilibrium parameters of the interaction between wheat ATI 
and TLR4.
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ATI-TLR4 complex). The equilibrium dissociation constant (KD,StrP = (1.4 ± 0.4) × 10−6 M) was compatible with 
the value measured upon binding between TLR4 and pepsin-digested ATI under reducing/alkylating conditions. 
Most interestingly, upon pre-saturation of TLR4 with 100 μM RSGNVGESGLI, the binding of ATI to the receptor 
Figure 2. Effect of ionic strength lowering on the interaction between ATI and surface-blocked TLR4. 
Superimposition of sensorgrams obtained at increasing concentrations of the bi-functional inhibitor, each at 
different ionic strength conditions.
Figure 3. Three-dimensional representation of the molecular docking of homology modelled wheat ATI 
CM3 (green ribbon) onto human TLR4-MD2 complex (grey ribbon). For better clarity of ATI-TLR4 complex 
visualization, MD2 molecule was removed after docking procedure. Black box highlights the oligopeptides 
constituting the discontinuous ATI binding interface. Oligopeptides are visualized as sticks (Panel A). Predicted 
cleavage sites by pepsin on wheat ATI CM3 (Panel B). The oligopeptides constituting the discontinuous ATI 
binding interface are highlighted in green. Residues constituting signal peptide (excluded from docking 
procedure) are highlighted in light blue.
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was largely prevented, as evident from the corresponding 50% reduction in the maximal response at equilibrium 
(Fig. 5, Panel C). To address the specificity of the peptide–receptor interaction, a scrambled version of the peptide 
(amino acid sequence: SGIVLSGGNRE, generated using RandSeq tool27) was tested both for its binding ability 
to TLR4 and for competitive activity to ATI: the scrambled counterpart showed no competitive activity (Fig. 5, 
Panel C), still being capable of binding to the receptor although with lower affinity (KD,ScrP = 9.9 × 10−6 M) (Fig. 5, 
Panel B).
Discussions
Toll-like receptors are ubiquitous in immune cells28,29, in which they mediate the stimulation of the innate 
response and enhance adaptive immunity against pathogens30. In this context, their activation may result in the 
onset of autoimmune, chronic inflammatory and infectious diseases31. Specifically, nutritional ATI proteins from 
wheat were reported to activate the TLR4–MD2–CD14 complex15 according to a lipopolysaccharide-like mecha-
nism, and elicit strong innate immune effects in vitro and in vivo, with consequent profound implications both in 
gastrointestinal inflammatory disorders (celiac disease, gluten sensitivity, irritable bowel syndrome, inflammatory 
bowel disease), and in non-intestinal inflammation.
According to a concerted approach based on surface plasmon resonance biosensor and molecular docking 
methods, we explored the interaction between a representative member of the structurally conserved ATI fam-
ily, namely CM3, and human TLR4, demonstrating ATI ability to directly target the receptor. The resulting 1:1 
ATI-TLR4 complex was characterized by KD in the nanomolar range. ATI binding to TLR4 occurred with fully 
comparable affinity to that of TLR4 physiological partner MD232, and similar to other ATI targets, such as diges-
tive serine proteases and amylases23. Additionally, wheat ATI CM3 preserved part of the native TLR4-binding 
ability upon in vitro enzymatic digestion, confirming the role of intramolecular disulphide bonds as key determi-
nants of wheat ATI capacity to survive gastro-intestinal transit and trigger TLR4 signalling25.
ATI-TLR4 complex was mainly stabilized by non-covalent electrostatic interactions, and changes in ionic 
strength significantly altered the dissociation rate and the stability of the complex. Specifically, kdiss and KD val-
ues increased nearly by a 25-fold factor in the presence of NaCl (up to 140 mM), as determined by analogous 
biosensor-based binding assays replicated under different ionic strength conditions, and in agreement with the 
results of the computational mapping of electrostatic potentials (see Fig. 2 and Supplemental Material).
Consistently with these experimental evidences, computational analysis predicted ATI molecule to favour-
ably accommodate within the β-strand loop of TLR4, in a binding region distinct from both MD2 and TLR4 
Figure 4. Binding of pepsin-digested ATI to surface-blocked TLR4. Comparison of responses obtained at 
increasing concentrations of the ATI digested under non-reducing (Panel A) and reducing conditions (Panel B).
Complex kass (M−1 s−1) kdiss (s−1) KD (M)
TLR4-ATI 41000 ± 6000 0.0025 ± 0.0006 (6.1 ± 1.7) × 10−8
TLR4-ATInonred_dig 6000 ± 400 0.0029 ± 0.0004 (4.8 ± 0.7) × 10−7
TLR4-ATIred_dig 3000 ± 350 0.0077 ± 0.0010 (2.6 ± 0.5) × 10−6
TLR4-RSGNVGESGLI 3620 ± 280 0.0050 ± 0.0012 (1.4 ± 0.4) × 10−6
Table 2. Comparison of kinetic and equilibrium parameters of the interaction between TLR4 and both ATI 
(either non-digested and digested by pepsin) and the oligopeptide constituting part of the ATI binding interface.
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self-dimerization interfaces33. The full agreement between computational and experimentally determined equi-
librium dissociation constants confirmed the quality of the predictive model.
Other works exploited the minimal binding region between TLR4 and a number of physiological binders 
thereof (MD234, MyD8835, and TRAM36) to prevent complex formation and inflammatory downstream effects. 
Analogously, the mapping of the binding interfaces of TLR4-ATI model (Fig. 3) was pivotal in guiding the design 
and the synthesis of an antagonist 11-mer oligopeptide (largely hydrolase-resistant, as predicted by sequence 
analysis). Preliminary docking studies predicted the binding interface between the 11-mer and TLR to be per-
fectly superimposable to that of ATI (see Supplemental Material); when tested for binding to TLR4, the oligopep-
tide specifically bound to the receptor with partly preserved binding affinity of the parent ATI molecule, but most 
interestingly successfully prevented the formation of the ATI-TLR4 complex in a biosensor-based competitive 
binding assay. Based on these promising results, we reasonably believe that this oligopeptide could inhibit the 
activation of ATI-induced inflammatory cascade, consistently with previous studies reporting the abrogation of 
IL-1β production upon treatment with ATI digested under reducing and alkylating conditions37.
In conclusion, our findings may have physiological and pharmacological implications not only for celiac dis-
ease and non-celiac gluten sensitivity, but also for other gastrointestinal inflammatory disorders. Furthermore, 
although demanding further customization (at this stage, the nearly 30-fold lower affinity and slower association 
kinetics with respect to ATI would require a large excess of the oligopeptide to interfere with the interaction with 
TLR4) the RSGNVGESGLI peptide can be used as the starting point for the rational design of ligands able to spe-
cifically block the interaction between TLR4 and its activators. Further studies are currently in progress.
Methods
Biosensor device. Binding experiments were performed on an evanescent wave/resonant mirror38 opti-
cal biosensor (IAsys plus - Affinity Sensors Ltd, Cambridge, UK), equipped with dual-well carboxylate cuvettes 
(NeoSensors, Ltd., UK). A working volume of 80 μL was used throughout, and the temperature was set at 37 °C. 
The possible influence of mass transport on the determination of kinetic parameters39 was considered and 
reduced by setting the stirrer rate to 95%.
Preparation of TLR4 surface. TLR4-functionalized surfaces were obtained following a previously reported 
protocol23. Briefly, carboxylate cuvettes were rinsed and equilibrated with PBS pH 7.4, and carboxylic groups were 
activated by EDC/NHS chemistry40. TLR4-His was solubilized in 10 mM CH3COONa, pH 4.5, then covalently 
coupled to the carboxylic surface via the N-terminus of the poly-His tail. To optimize surface density, different 
stock solutions of TLR4-His with concentrations in the range 200–1000 μg/mL were tested: 400 μg/mL was finally 
selected as it minimized steric hindrance, and at the same time prevented the dimerization between blocked 
TLR4-His macromolecules, both events being likely to reduce the number of available binding sites on the sens-
ing surface. Free carboxylic sites on the sensor surface were inactivated by treatment with 1 M ethanolamine, pH 
8.5. The surface was finally re-equilibrated with PBS.
The resulting shifts in the baseline (ΔR = 700–800 arcsec) generally indicated the assembly of a partial recep-
tor monolayer for a 100 kDa protein (approximately 70% surface occupancy) corresponding to a final surface 
density of 1.20–1.30 ng/mm2, approximately equivalent to 9–10 mg/mL.
The use of CH3COONa 10 mM, pH 4.5 as immobilization buffer (chosen on the basis of TLR4-His isoelectric 
point 5.88) allowed an efficient immobilization. Negative baseline drift signals in TLR4 surface were not observed 
with time or upon multiple washes, confirming that the receptor molecules were irreversibly linked to the sensor 
surface.
Figure 5. Binding of ATI-derived oligopeptides to surface-blocked TLR4. Superimposition of sensorgrams 
obtained at increasing concentrations of the straight peptide (RSGNVGESGLI, Panel A), and of the scrambled 
counterpart (SGIVLSGGRNE, Panel B). Competitive binding to TLR4 (Panel C). Comparison of binding of ATI 
to free surface-blocked TLR4, and upon pre-saturation of the receptor with RSGNVGESGLI (#-marked curve) 
and with SGIVLSGGRNE (*-marked curve).
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Determination of kinetic and equilibrium constants. Wheat ATI CM3 was added at six different con-
centrations in the range 16–600 nM to the TLR4 surface, each time monitoring association kinetics to equilibrium 
(approximately 2–4 min, depending on the concentration of ATI) prior to start dissociation phase.
Dissociation steps were performed with a single wash with PBS buffer, whereas baseline recovery was achieved 
by multiple washes with PBS supplemented with 200 mM NaCl, as ionic strength decreased the stability of the 
complex without affecting the functionality of the surface.
The determination of rate and equilibrium parameters was performed as described in detail elsewhere41. 
Briefly, upon addition of soluble ATI to surface-blocked TLR4, the amount of the ATI-TLR4 complex formed in 
time t, is given by:
ATI TLR ATI TLR e[ 4] [ 4] [1 ] (1)t eq
k ton− = − − −
where [ATI − TLR4]eq is the concentration of complex at equilibrium. kon is the concentration-dependent, 
pseudo-first order rate constant for the interaction where:
k k ATI k[ ] (2)on ass diss= +
The instrumental response is proportional to the mass of bound ligand, resulting in:
R R R e R( )[1 ] (3)t eq
k t
0 0
on= − − +−
where Rt is the response at time t, R0 is the initial response, and Req the maximal response at equilibrium for a 
given ligand concentration. From the fit of raw data, kon values can be determined at any given concentration of 
ligand.
Hence, kass and kdiss were derived from the kon vs ATI concentration plot. Equilibrium dissociation constant 
values were obtained both from the ratio of kinetic constants (KD = kdiss/kass), and from the extent of the binding 
measured at equilibrium for any ligand concentration. In fact:
R R
1 (4)
eq max
ATI
K
ATI
K
[ ]
[ ]
D
D
=
+
where Rmax is the response at equilibrium obtained at asymptotic concentration of ligand. Once a complex has 
been formed, it will eventually dissociate into its components. Usually, the dissociation of surface-bound com-
plexes may be described by:
= −R Ae (5)t
k tdiss
A is the extent of the dissociation phase. Binding analyses were repeated under different conditions to assess the 
influence of pH and ionic strength on the interaction (in the range of pH between 6 and 8, and salt concentration 
between 20 and 140 mM, respectively).
Raw binding data were analysed using the Fast Fit software (Fison Applied Sensor Technology) as previously 
reported42: the software uses an iterative curve-fitting to derive the observed rate constant and the maximum 
response at equilibrium due to ligand binding at a particular ligand concentration. Local and global fit analysis 
of the interaction data generally revealed monophasic kinetics. Specifically, mono-exponential analysis of associ-
ation curves residuals was not affected by measurable systematic errors (a bi-exponential model did not signifi-
cantly improve the quality of the fit as judged by an F-test, 95% confidence).
As a proof of specificity, wheat ATI produced non-significant signal upon addition to a bare carboxylate 
surface.
Prediction of three-dimensional structure of wheat ATI. ATI CM3 precursor protein query sequence 
(P17314.143) was obtained from UniProt database. The signal peptide (MACKSSCSLLLLAVLLSVLAAASA) was 
predicted using SignalP44, and the N-terminus sequence shortened accordingly. Fold-recognition was performed 
using I-Tasser45, the best structural templates being: 1B1U46, 4CVW47, 1BEA48, 1BFA48. The best predicted model 
had a TM-Score of 0.67 ± 0.13 (TM-score > 0.5 indicates a model of correct topology49). The model was refined 
and validated with Chiron-Gaia50,51.
Protein-protein docking analysis. The predictive model of the complex between wheat ATI CM3 
(UniProtKB ID: P17314) and human TLR4 was computed by docking ATI CM3 (obtained by fold-recognition) 
onto the crystallographic structure of the receptor (PDB ID: 3FXI33). Rigid docking was performed using 
PatchDock server52,53, ATI CM3 and TLR4 being uploaded as ligand and receptor, respectively, and FireDock54,55 
was used for interaction refinement. Settings were always kept to default values. The best scoring complex and 
all images were rendered with PyMOL (The PyMOL Molecular Graphics System, Version 1.3 Schrödinger, LLC).
Protein-peptide docking analysis. The most probable binding site for RSGNVGESGLI oligopeptide on 
human TLR4 (PDB ID: 3FXI33) was identified by flexible docking using the Autodock Vina software (version 
1.1.2)56 on an Intel Core i7/Mac OSX 10.12-based platform. Hydrogen atoms were added to the receptor protein 
prior to any analysis. RSGNVGESGLI peptide was designed and energy minimized using Avogadro57 (Force field: 
MMFF94; Number of steps: 500; Algorithm: Conjugate gradients; Convergence: 10−7). Autodock Vina (a software 
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performing a Lamarckian genetic algorithm to explore the binding possibilities of a ligand in a binding pocket58) 
was used with a grid of 76, 70, and 65 Å (in the x, y, and z directions) around the receptor, with a grid spacing of 
0.375 Å, a root-mean-square (rms) tolerance of 0.8 Å, and a maximum of 2,500,000 energy evaluations. Other 
parameters were set to default values59. The obtained model has been further refined using NNScore60.
Calculation of electrostatic potential maps. Electrostatic potential maps were determined using 
PDB2PQR server61 (including the APBS web solver), uploading the three-dimensional structures, and setting the 
parameters as default (Force field: PARSE). PROPKA was used for the determination of pKa.
ATI digestion using pepsin under reducing conditions. ATI was treated in sequence with 2% 
2-mercaptoethanol (10 min at 25 °C) to reduce intramolecular disulfide bonds, and with 14 mM iodoacetamide 
(30 min at 25 °C) to prevent re-oxidation of the thiols62. Resulting sample was extensively dialyzed against 20 mM 
sodium acetate, 150 mM NaCl, pH 4.0 to remove 2-mercaptoethanol and iodoacetamide, and eventually digested 
with pepsin according to the method described by Lin et al.63. Briefly, ATI was incubated with pepsin at 4 °C for 
48 h, and the reaction was blocked by neutralization (pH = 7) with NaOH. The hydrolysis product was processed 
for binding to surface-blocked TLR4 as described above.
Statistical analysis. Results were expressed as mean values ± standard deviation of results obtained from 
three independent experiments. Statistical analysis was performed with one-way ANOVA, followed by the 
Bonferroni test using Sigma-stat 3.1 software (SPSS, Chicago, IL, USA). p values < 0.01 were considered statisti-
cally significant.
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